Literature DB >> 8453873

Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults.

C N Anigbogu1, S A Adigun, I Inyang, B J Adegunloye.   

Abstract

The effects of chloroquine on resting blood pressure, forearm blood flow (FBF), and forearm vascular resistance (FVR) and on the responses to cold stimulation were studied in healthy young adults. Chloroquine sulphate (800 mg) reduced systolic pressure and increased FBF (P < 0.05) but had no effect on resting FVR. Cold immersion increased systolic pressure (from 108.8 +/- 1.7 mmHg to 127.8 +/- 6.9 mmHg; P < 0.05) diastolic pressure (from 73.4 +/- 2.7 to 95.2 +/- 6.2 mmHg; P < 0.01) and FVR (from 5.9 +/- 0.9 to 13.0 +/- 1.9 a.u.; P < 0.001) but reduced FBF (from 14.3 +/- 1.64 to 10.1 +/- 1.29 ml min-1; P < 0.05). Chloroquine reduced the increase in FVR reduced by cold stimulation (P < 0.01), but had little effect on the BF and FBF responses to cold stimulation. The hypotensive effect of chloroquine could be attributed, at least in part, to the observed fall in vascular resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453873     DOI: 10.1111/j.1475-097x.1993.tb00381.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  10 in total

1.  Syncope following oral chloroquine administration in a hypertensive patient controlled on amlodipine.

Authors:  A A Leslie Ajayi; A Q Adigun
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

2.  Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

3.  Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.

Authors:  Chun Li; X R Wang; H J Ji; X Y Zhang; X F Li; L Z Wang; C H Wang; Y F Wang; Rong Yang; G C Wang; Xin Lu; Ping Zhu; L N Chen; H T Jin; J T Liu; X Y Liu; Lin Sun; H Y Chen; Ping Wei; J X Wang; L F Cui; Rong Shu; B L Liu; Z L Zhang; G T Li; Z B Li; Jing Yang; J F Li; Bin Jia; F X Zhang; J M Tao; S L Han; J Y Lin; M Q Wei; X M Liu; Dan Ke; S X Hu; Cong Ye; X Y Yang; Hao Li; C B Huang; Ming Gao; Bei Lai; X F Li; L J Song; Yi Wang; X Y Wang; Y D Tang; Yin Su; Rong Mu; Z G Li
Journal:  Clin Rheumatol       Date:  2017-03-24       Impact factor: 2.980

4.  Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension.

Authors:  Kang Wu; Qian Zhang; Xiongting Wu; Wenju Lu; Haiyang Tang; Zhihao Liang; Yali Gu; Shanshan Song; Ramon J Ayon; Ziyi Wang; Kimberly M McDermott; Angela Balistrieri; Christina Wang; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Jian Wang
Journal:  Br J Pharmacol       Date:  2017-10-02       Impact factor: 8.739

Review 5.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

6.  Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells.

Authors:  D Ghigo; E Aldieri; R Todde; C Costamagna; G Garbarino; G Pescarmona; A Bosia
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

7.  Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.

Authors:  Chaisith Sivakorn; Polrat Wilairatana; Srivicha Krudsood; Marcus J Schultz; Tachpon Techarang; Khanittha Kheawsawaung; Arjen M Dondorp
Journal:  Malar J       Date:  2021-01-07       Impact factor: 2.979

8.  Letter: Multiple Factors Could Affect Blood Pressure in Patients With COVID-19.

Authors:  Burak Açar
Journal:  Angiology       Date:  2022-03-03       Impact factor: 3.299

9.  Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.

Authors:  Young Hee Rho; Annette Oeser; Cecilia P Chung; Ginger L Milne; C Michael Stein
Journal:  Arch Drug Inf       Date:  2009-06

10.  Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models.

Authors:  Shailaja B Khobragade; Pankaj Gupta; Prashant Gurav; Girish Chaudhari; Madhumanjiri M Gatne; Vyas M Shingatgeri
Journal:  J Pharmacol Pharmacother       Date:  2013-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.